Characterization of a fully human monoclonal antibody against extracellular domain of matrix protein 2 of influenza A virus

Antiviral Research

Volumn 91, Issue 3, 2011, Pages 283-287

  Ozawa, Tatsuhiko ^a   Jin, Aishun ^a,b   Tajiri, Kazuto ^a   Takemoto, Masaya ^a   Okuda, Tomoko ^a   Shiraki, Kimiyasu ^a   Kishi, Hiroyuki ^a   Muraguchi, Atsushi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Antibody therapeutics; Influenza; M2e antibody

Indexed keywords

HUMAN MONOCLONAL ANTIBODY; MATRIX PROTEIN;

2009 H1N1 INFLUENZA; ARTICLE; AVIAN INFLUENZA; AVIAN INFLUENZA VIRUS; BINDING AFFINITY; BLOOD; CELL DIFFERENTIATION; CONTROLLED STUDY; HUMAN; IMMUNE RESPONSE; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; LONG TERM CARE; NONHUMAN; PANDEMIC; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN DOMAIN; VIRUS; VIRUS STRAIN; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; B-LYMPHOCYTES; BIRDS; ENZYME-LINKED IMMUNOSPOT ASSAY; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; INFLUENZA, HUMAN; LAB-ON-A-CHIP DEVICES; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY; SINGLE-CELL ANALYSIS; VIRAL MATRIX PROTEINS;

AVES; INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

EID: 79960462900     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2011.06.012     Document Type: Article

References (24)

1. Beerli R.R., Bauer M., Schmitz N., Buser R.B., Gwerder M., Muntwiler S., Renner W.A., Saudan P., Bachmann M.F. Prophylactic and therapeutic activity of fully human monoclonal antibodies directed against influenza A M2 protein. Virol. J. 2009, 6:224.
2. Black R.A., Rota P.A., Gorodkova N., Klenk H.D., Kendal A.P. Antibody response to the M2 protein of influenza A virus expressed in insect cells. J. Gen. Virol. 1993, 74:143-146.
3. De Filette M., Martens W., Roose K., Deroo T., Vervalle F., Bentahir M., Vandekerckhove J., Fiers W., Saelens X. An influenza A vaccine based on tetrameric ectodomain of matrix protein 2. J. Biol. Chem. 2008, 283:11382-11387.
4. Fan J., Liang X., Horton M.S., Perry H.C., Citron M.P., Heidecker G.J., Fu T.M., Joyce J., Przysiecki C.T., Keller P.M., Garsky V.M., Ionescu R., Rippeon Y., Shi L., Chastain M.A., Condra J.H., Davies M.E., Liao J., Emini E.A., Shiver J.W. Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys. Vaccine 2004, 22:2993-3003.
5. Feng J., Zhang M., Mozdzanowska K., Zharikova D., Hoff H., Wunner W., Couch R.B., Gerhard W. Influenza A virus infection engenders a poor antibody response against the ectodomain of matrix protein 2. Virol. J. 2006, 3:102.
6. Frace A.M., Klimov A.I., Rowe T., Black R.A., Katz J.M. Modified M2 proteins produce heterotypic immunity against influenza A virus. Vaccine 1999, 17:2237-2244.
7. Fu T.M., Freed D.C., Horton M.S., Fan J., Citron M.P., Joyce J.G., Garsky V.M., Casimiro D.R., Zhao Q., Shiver J.W., Liang X. Characterizations of four monoclonal antibodies against M2 protein ectodomain of influenza A virus. Virology 2009, 385:218-226.
8. Gabbard J., Velappan N., Di Niro R., Schmidt J., Jones C.A., Tompkins S.M., Bradbury A.R. A humanized anti-M2 scFv shows protective in vitro activity against influenza. Protein. Eng. Des. Sel. 2009, 22:189-198.
9. Holsinger L.J., Lamb R.A. Influenza virus M2 integral membrane protein is a homotetramer stabilized by formation of disulfide bonds. Virology 1991, 183:32-43.
10. Hughey P.G., Roberts P.C., Holsinger L.J., Zebedee S.L., Lamb R.A., Compans R.W. Effects of antibody to the influenza A virus M2 protein on M2 surface expression and virus assembly. Virology 1995, 212:411-421.
11. Ilyushina N.A., Hoffmann E., Salomon R., Webster R.G., Govorkova E.A. Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice. Antivir. Ther. 2007, 12:363-370.
12. Ito T., Gorman O.T., Kawaoka Y., Bean W.J., Webster R.G. Evolutionary analysis of the influenza A virus M gene with comparison of the M1 and M2 proteins. J. Virol. 1991, 65:5491-5498.
13. Jin A., Ozawa T., Tajiri K., Obata T., Kondo S., Kinoshita K., Kadowaki S., Takahashi K., Sugiyama T., Kishi H., Muraguchi A. A rapid and efficient single-cell manipulation method for screening antigen-specific antibody-secreting cells from human peripheral blood. Nat. Med. 2009, 15:1088-1092.
14. Lamb R.A., Lai C.J., Choppin P.W. Sequences of mRNAs derived from genome RNA segment 7 of influenza virus: colinear and interrupted mRNAs code for overlapping proteins. Proc. Natl. Acad. Sci. USA 1981, 78:4170-4174.
15. Lamb R.A., Zebedee S.L., Richardson C.D. Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface. Cell 1985, 40:627-633.
16. Liu W., Chen Y.H. High epitope density in a single protein molecule significantly enhances antigenicity as well as immunogenicity: a novel strategy for modern vaccine development and a preliminary investigation about B cell discrimination of monomeric proteins. Eur. J. Immunol. 2005, 35:505-514.
17. Masihi K.N., Schweiger B., Finsterbusch T., Hengel H. Low dose oral combination chemoprophylaxis with oseltamivir and amantadine for influenza A virus infections in mice. J. Chemother. 2007, 19:295-303.
18. Mozdzanowska K., Feng J., Eid M., Kragol G., Cudic M., Otvos L., Gerhard W. Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2. Vaccine 2003, 21:2616-2626.
19. Neirynck S., Deroo T., Saelens X., Vanlandschoot P., Jou W.M., Fiers W. A universal influenza A vaccine based on the extracellular domain of the M2 protein. Nat. Med. 1999, 5:1157-1163.
20. Okuda K., Ihata A., Watabe S., Okada E., Yamakawa T., Hamajima K., Yang J., Ishii N., Nakazawa M., Okuda K., Ohnari K., Nakajima K., Xin K.Q. Protective immunity against influenza A virus induced by immunization with DNA plasmid containing influenza M gene. Vaccine 2001, 19:3681-3691.
21. Sugrue R.J., Hay A.J. Structural characteristics of the M2 protein of influenza A viruses: evidence that it forms a tetrameric channel. Virology 1991, 180:617-624.
22. Wang R., Song A., Levin J., Dennis D., Zhang N.J., Yoshida H., Koriazova L., Madura L., Shapiro L., Matsumoto A., Yoshida H., Mikayama T., Kubo R.T., Sarawar S., Cheroutre H., Kato S. Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein. Antiviral Res. 2008, 80:168-177.
23. Zebedee S.L., Lamb R.A. Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions. J. Virol. 1988, 62:2762-2772.
24. Zebedee S.L., Lamb R.A. Nucleotide sequences of influenza A virus RNA segment 7: a comparison of five isolates. Nucleic Acids Res. 1989, 17:2870.